Suppr超能文献

肝硬化患者维生素B6代谢的肝脏酶活性

Activities of the hepatic enzymes of vitamin B6 metabolism for patients with cirrhosis.

作者信息

Merrill A H, Henderson J M, Wang E, Codner M A, Hollins B, Millikan W J

出版信息

Am J Clin Nutr. 1986 Oct;44(4):461-7. doi: 10.1093/ajcn/44.4.461.

Abstract

Patients with cirrhosis and other hepatic diseases frequently exhibit lower concentrations of plasma pyridoxal 5'-phosphate (PLP), which is derived primarily from liver. To determine the biochemical basis for this abnormality, the enzymes of vitamin B6 metabolism--pyridoxal kinase, pyridoxine (pyridoxamine) 5'-phosphate oxidase, PLP phosphatase(s), and pyridoxal oxidase(s)--were analyzed in liver. The activities of the two biosynthetic enzymes, pyridoxal kinase and pyridoxine (pyridoxamine) 5'-phosphate oxidase were similar for both. The phosphatase activities were significantly higher (mean +/- SD of 9.55 +/- 8.03 versus 3.97 +/- 2.36 nmol X min X mg protein, p less than 0.05) for cirrhotics. Pyridoxal oxidase activities appeared slightly lower for cirrhotics. There was considerable variation in many indices of liver function, which suggests that the defects contributing to altered vitamin B6 metabolism may be complex and individualistic. These analyses have shown that cirrhotics are capable of apparently normal PLP synthesis and that increased hepatic dephosphorylation may be responsible for low levels of plasma PLP.

摘要

肝硬化及其他肝脏疾病患者的血浆磷酸吡哆醛(PLP)浓度常常较低,而PLP主要来源于肝脏。为了确定这种异常情况的生化基础,对肝脏中维生素B6代谢的相关酶——吡哆醛激酶、吡哆醇(吡哆胺)5'-磷酸氧化酶、PLP磷酸酶以及吡哆醛氧化酶进行了分析。两种生物合成酶,即吡哆醛激酶和吡哆醇(吡哆胺)5'-磷酸氧化酶的活性在两者中相似。肝硬化患者的磷酸酶活性显著更高(平均值±标准差分别为9.55±8.03与3.97±2.36 nmol·min·mg蛋白,p<0.05)。肝硬化患者的吡哆醛氧化酶活性似乎略低。许多肝功能指标存在相当大的差异,这表明导致维生素B6代谢改变的缺陷可能是复杂且因人而异的。这些分析表明,肝硬化患者能够进行明显正常的PLP合成,而肝脏脱磷酸作用增强可能是血浆PLP水平较低的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验